Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -34.17%11.26K | 0 | 0 | -92.75%26.99K | -76.69%4.57K | 198.55%17.1K | -99.33%1.19K | -97.56%4.14K | 25.15%372.25K | -45.88%19.59K |
| Operating revenue | -34.17%11.26K | --0 | --0 | -92.75%26.99K | -76.69%4.57K | 198.55%17.1K | -99.33%1.19K | -97.56%4.14K | 25.15%372.25K | -45.88%19.59K |
| Cost of revenue | 0 | |||||||||
| Gross profit | 90.30%372.25K | |||||||||
| Operating expense | -7.67%1.31M | 53.44%1.13M | 36.30%1.85M | -32.03%4.59M | -45.49%1.09M | 29.76%1.41M | -66.12%736.81K | -9.47%1.35M | 8.32%6.76M | 9.15%2M |
| Selling and administrative expenses | 31.91%1.09M | 87.70%717.54K | 100.69%1.65M | -20.49%2.8M | -4.61%766.96K | 92.26%825.37K | -74.49%382.28K | 4.64%821.99K | 2.64%3.52M | -17.29%804.04K |
| -Selling and marketing expense | 4,921.32%699.67K | 1,017.43%341.2K | 19.98%454.15K | -7.67%691.74K | 25.84%268.75K | --13.93K | -87.43%30.53K | 29.33%378.52K | 11.04%749.16K | 40.65%213.55K |
| -General and administrative expense | -52.05%389.06K | 6.99%376.34K | 169.58%1.2M | -23.97%2.1M | -15.63%498.22K | 89.01%811.44K | -71.99%351.75K | -10.02%443.47K | 0.58%2.77M | -28.01%590.48K |
| Research and development costs | -71.18%137.7K | 14.31%315.79K | -64.92%156.75K | -43.97%1.43M | -76.32%229.66K | -9.01%477.84K | -45.62%276.26K | -18.85%446.86K | 20.99%2.55M | 63.74%969.65K |
| Depreciation amortization depletion | -75.87%5.55K | -70.13%6.82K | -125.70%-5.95K | -53.13%91.76K | -47.05%22.78K | -52.49%22.99K | -58.42%22.82K | -53.16%23.16K | -9.20%195.76K | -13.59%43.03K |
| -Depreciation and amortization | -75.87%5.55K | -70.13%6.82K | -125.70%-5.95K | -53.13%91.76K | -47.05%22.78K | -52.49%22.99K | -58.42%22.82K | -53.16%23.16K | -9.20%195.76K | -13.59%43.03K |
| Other operating expenses | -16.19%73.55K | 63.07%90.41K | -27.57%44.7K | -44.10%275.4K | -61.46%70.48K | 1.11%87.77K | -51.11%55.44K | -43.71%61.72K | 1.10%492.71K | -16.07%182.87K |
| Operating profit | 7.34%-1.29M | -53.69%-1.13M | -36.72%-1.85M | 28.49%-4.57M | 45.19%-1.09M | -28.87%-1.4M | 63.18%-735.62K | -1.80%-1.35M | -5.66%-6.39M | -8.37%-1.98M |
| Net non-operating interest income (expenses) | -52.15%-380.64K | -56.18%-383.79K | -13.58%-253.84K | 5.53%-984.85K | -0.08%-265.44K | 6.79%-250.17K | 6.47%-245.74K | 9.22%-223.5K | 8.75%-1.04M | 9.58%-265.21K |
| Non-operating interest income | --0 | ---- | ---- | --301 | --0 | --301 | ---- | ---- | --0 | --0 |
| Non-operating interest expense | 51.97%380.64K | 56.18%383.79K | 13.58%253.84K | -5.51%985.15K | 0.08%265.44K | -6.68%250.48K | -6.47%245.74K | -9.22%223.5K | -8.75%1.04M | -9.09%265.21K |
| Other net income (expenses) | -60.72%71.16K | 2,990.46%214.05K | 17,807.97%124.49K | 151.49%150.94K | 83.38%-36.44K | 450.47%181.17K | 107.09%6.93K | -100.93%-703 | 94.84%-293.14K | 96.17%-219.25K |
| Gain on sale of security | -38.03%112.28K | 3,036.14%217.21K | 38,330.01%268.76K | 170.18%118.94K | -160.30%-68.44K | 483.21%181.17K | 107.09%6.93K | -100.93%-703 | -68.02%44.02K | -59.97%113.5K |
| Special income (charges) | --14.98K | --236 | ---117.07K | --0 | --0 | --0 | --0 | --0 | 95.47%-263.57K | 95.67%-259.15K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.18%48.09K | ---- |
| -Less:Other special charges | --125 | ---- | --121.26K | ---- | ---- | ---- | ---- | ---- | 123.84%164.8K | ---- |
| -Less:Write off | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -99.29%4.42K | -100.00%6 |
| -Gain on sale of property,plant,equipment | --15.11K | --236 | --4.19K | --0 | --0 | --0 | --0 | --0 | ---46.26K | ---- |
| Other non-operating income (expenses) | ---56.1K | ---3.4K | ---27.2K | 143.48%32K | ---- | ---- | ---- | ---- | ---73.6K | ---- |
| Income before tax | -9.41%-1.6M | -33.44%-1.3M | -25.46%-1.97M | 30.06%-5.4M | 43.71%-1.39M | -4.41%-1.47M | 58.68%-974.43K | -5.17%-1.57M | 39.99%-7.72M | 68.61%-2.46M |
| Income tax | -89.79K | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -9.41%-1.6M | -33.44%-1.3M | -25.46%-1.97M | 31.22%-5.31M | 47.36%-1.3M | -4.41%-1.47M | 58.68%-974.43K | -5.17%-1.57M | 37.60%-7.72M | 66.51%-2.46M |
| Net income continuous operations | -9.41%-1.6M | -33.44%-1.3M | -25.46%-1.97M | 31.22%-5.31M | 47.36%-1.3M | -4.41%-1.47M | 58.68%-974.43K | -5.17%-1.57M | 37.60%-7.72M | 66.51%-2.46M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -9.41%-1.6M | -33.44%-1.3M | -25.46%-1.97M | 31.22%-5.31M | 47.36%-1.3M | -4.41%-1.47M | 58.68%-974.43K | -5.17%-1.57M | 37.60%-7.72M | 66.51%-2.46M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -9.41%-1.6M | -33.44%-1.3M | -25.46%-1.97M | 31.22%-5.31M | 47.36%-1.3M | -4.41%-1.47M | 58.68%-974.43K | -5.17%-1.57M | 37.60%-7.72M | 66.51%-2.46M |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | -100.00%-0.02 | 37.50%-0.05 | 66.67%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 46.67%-0.08 | 66.67%-0.03 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | -100.00%-0.02 | 37.50%-0.05 | 66.67%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 46.67%-0.08 | 66.67%-0.03 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.